Diversity Action Plans Should Be Brief And Waiver Requests Filed Early, US FDA Says

 
• By Sue Sutter
  
Diverse hands
The FDA expects studies can be conducted with diversity action plans 'in most cases.' • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Diversity & Inclusion

More from Clinical Trials